NasdaqCM - Delayed Quote USD
GlycoMimetics, Inc. (GLYC)
0.1570
-0.0090
(-5.42%)
At close: June 13 at 4:00:01 PM EDT
0.1507
-0.01
(-4.01%)
After hours: June 13 at 7:49:13 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-25,695.2410
-31,098.0780
-34,879.9030
-46,457.4880
-57,489.5300
Investing Cash Flow
27.4670
20.0280
-21.3940
-84.1910
-14.9430
Financing Cash Flow
0.5000
5.3980
28,823.5080
4,157.4080
10,724.3460
End Cash Position
5,614.1860
10,720.1780
41,792.8300
47,870.6190
90,254.8900
Capital Expenditure
--
-9.9720
-21.3940
-84.1910
-14.9430
Issuance of Capital Stock
--
0
28,707.0110
4,157.4080
10,699.3170
Free Cash Flow
-25,697.7740
-31,108.0500
-34,901.2970
-46,541.6790
-57,504.4730
12/31/2021 - 1/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABP Abpro Corporation
0.2150
-11.85%
ONCO Onconetix, Inc.
4.7300
-24.90%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4121
+14.79%
ERNA Ernexa Therapeutics Inc.
2.2900
-3.38%
EQ Equillium, Inc.
0.3470
-10.22%
VRPX Virpax Pharmaceuticals, Inc.
0.2320
-2.93%
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
ADTX Aditxt, Inc.
1.3800
-4.83%
REVB Revelation Biosciences, Inc.
0.7940
-1.03%
CGTX Cognition Therapeutics, Inc.
0.2983
-3.15%